Molecure S.A. Cash Flow-to-Debt Ratio
Molecure S.A. cash flow-to-debt ratio. Molecure S.A. (MOC) has a Cash Flow-to-Debt Ratio of 2.83x as of March 2025, meaning its operating cash flow of zł26.15 Million could theoretically repay 3% of its total liabilities (zł9.24 Million) in one year. Check Molecure S.A. (MOC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Molecure S.A. (2015–2024)
Cash flow-to-debt ratio of Molecure S.A. from 2015 to 2024. Historical debt coverage capacity for Molecure S.A. across 10 annual periods. Check MOC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Molecure S.A. Cash Flow-to-Debt Ratio by Year (2015–2024)
Molecure S.A. cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Molecure S.A.. For the full cash flow conversion analysis, see cash flow conversion of Molecure S.A..
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.53x | zł-56.99 Million | zł10.31 Million | ▼ -169.2% |
| 2023 | -2.05x | zł-23.29 Million | zł11.34 Million | ▼ -133.4% |
| 2022 | -0.88x | zł-10.21 Million | zł11.61 Million | ▲ +31.9% |
| 2021 | -1.29x | zł-13.50 Million | zł10.45 Million | ▼ -122.7% |
| 2020 | 5.69x | zł57.44 Million | zł10.09 Million | ▲ +624.9% |
| 2019 | -1.08x | zł-7.11 Million | zł6.56 Million | ▲ +8.6% |
| 2018 | -1.19x | zł-4.89 Million | zł4.12 Million | ▼ -858.3% |
| 2017 | -0.12x | zł-599.63K | zł4.85 Million | ▲ +78.5% |
| 2016 | -0.57x | zł-1.44 Million | zł2.51 Million | ▲ +59.0% |
| 2015 | -1.40x | zł-1.53 Million | zł1.09 Million | — |